Partially matched related donor transplantation can achieve outcomes comparable with unrelated donor transplantation for patients with hematologic malignancies

Clinical Cancer Research

Volumn 15, Issue 14, 2009, Pages 4777-4783

  Huang, Xiao Jun ^a   Xu, Lan Ping ^a   Liu, Kai Yan ^a   Liu, Dai Hong ^a   Wang, Yu ^a   Chen, Huan ^a   Chen, Yu Hong ^a   Han, Wei ^a   Wang, Jing Zhi ^a   Chen, Yao ^a   Zhang, Xiao Hui ^a   Shi, Hong Xia ^a   Wang, Feng Rong ^a   Tang, Fei Fei ^a  

^a PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

IMATINIB;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ACUTE LYMPHOCYTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ARTICLE; CANCER MORTALITY; CANCER RELAPSE; CANCER SURVIVAL; CHILD; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DONOR LYMPHOCYTE INFUSION; DONOR SELECTION; ENGRAFTMENT; FEMALE; FOLLOW UP; GRAFT VERSUS HOST REACTION; HEMATOLOGIC MALIGNANCY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; INCIDENCE; INFANT; MAJOR CLINICAL STUDY; MALE; MYELODYSPLASTIC SYNDROME; NEWBORN; ORGAN DONOR; OUTCOME ASSESSMENT; PRESCHOOL CHILD; PRIORITY JOURNAL; RISK ASSESSMENT; SCHOOL CHILD; T CELL DEPLETION;

ACUTE DISEASE; ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; FEMALE; GRAFT VS HOST DISEASE; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY TESTING; HUMANS; LEUKEMIA; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT (HEALTH CARE); SURVIVAL ANALYSIS; SURVIVAL RATE; TISSUE DONORS; YOUNG ADULT;

EID: 68049096309     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-09-0691     Document Type: Article

References (29)

1. Szydlo R, Goldman JM, Klein JP, et al. Results of allogeneic bone marrow transplants for leukemia using donors other than HLA identical siblings. J Clin Oncol 1997;15:1717-1777 (Pubitemid 27209503)
2. Petersdorf EW, Gooley TA, Anasetti C, et al. Optimizing outcome after unrelated marrow transplantation by comprehensive matching of HLA class I and II alleles in the donor and recipient. Blood 1998;92: 3515-3520 (Pubitemid 28525174)
3. Hansen JA, Gooley TA, Martin PJ, et al. Bone marrow transplants from unrelated donors for patients with chronic myeloid leukemia. N Engl J Med 1998;338: 962-968 (Pubitemid 28152837)
4. Chen YH, Huang XJ, Xu LP, et al. A comparative study of peripheral blood stem cell vs bone marrow transplantation from unrelated donors. Zhonghua nei ke za zhi [Chinese journal of internal medicine] 2006; 45:624-627
5. Carreras E, Jiménez M, Gómez-García V, et al. Donor age and degree of HLA matching have a major impact on the outcome of unrelated donor haematopoietic cell transplantation for chronic myeloid leukaemia. Bone MarrowTransplant 2006;37:33-40. (Pubitemid 43135312)
6. Benito AI, Diaz MA, Gonzalez-Vicent M, Sevilla J, Madero L. Hematopoietic stem cell transplantation using umbilical cord blood progenitors: review of current clinical results. Bone MarrowTransplant 2004;33: 675-690 (Pubitemid 38499920)
7. Gluckman E, Rocha V, Arcese W, et al. Factors associated with outcomes of unrelated cord blood transplant: guidelines for donor choice. Exp Hematol 2004;32:397-407. (Pubitemid 38410917)
8. Godder KT, Hazlett LJ, Abhyankar SH, et al. Partially mismatched related-donor bone marrow transplantation for pediatric patients with acute leukemia: younger donors and absence of peripheral blasts improve outcome. J Clin Oncol 2000;18:1856-1866
9. Klingebiel T, Handgretinger R, Lang P, Bader P, Niethammer D. Haplo-identical transplantation for acute lymphoblastic leukemia in childhood. Blood Rev 2004;18:181-192 (Pubitemid 38859628)
10. Aversa F, Tabilio A, Velardi A, et al. Treatment of highrisk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype. N Engl J Med 1998;339:1186-1193 (Pubitemid 28482127)
11. Aversa F, Terenzi A, Felicini R. Haplo-identical stem cell transplantation for acute leukemia. Int J Hematol 2002;7:165-168
12. Aversa F, Martelli MF. Transplantation of haploidentically mismatched stem cells for the treatment of malignant diseases. Springer Semin Immunopathol 2004;26:155-168 (Pubitemid 40021964)
13. Huang XJ, Liu DH, Liu KY, et al. Haploidentical hematopoietic stem cell transplantation without in vitro Tcell depletion for the treatment of hematological malignancies. Bone Marrow Transplant 2006;38: 291-297
14. Lu DP, Dong LJ, Wu T, et al. Conditioning including antithymocyte globulin followed by unmanipulated HLA-mismatched/haploidentical blood and marrow transplantation can achieve comparable outcomes with HLA-identical sibling transplantation. Blood 2006;107:3065-3073
15. Huang XJ, Liu DH, Liu KY, et al. Treatment of acute leukaemia with unmanipulated HLA-mismatched/haploidentical blood and bone marrow transplantation. Biol Bone Marrow Transplant 2009; 15:257-265
16. Huang XJ, Xu LP, Liu KY, et al. HLA-mismatched/haploidentical hematopoietic stem cell transplantation without in vitro Tcell depletion for chronic myeloid leukemia: improved outcomes in patients in accelerated phase and blast crisis phase. Ann Med 2008;40: 444-455
17. Huret JL, Le Minor S, Dorkeld F, Dessen P, Bernheim A. Atlas of genetics and cytogenetics in oncology and haematology, an interactive database. Nucleic Acids Res 2000;28:349-351 (Pubitemid 30047804)
18. Huang XJ, Liu DH, Liu KY, Xu LP, Chen H, Han W. Donor lymphocyte infusion for the treatment of leukemia relapse after HLA-mismatched/haplo-identical T-cell-replete hematopoietic stem cell transplantation. Haematologica 2007;92:414-417 (Pubitemid 350143554)
19. Huang XJ, Guo NL, Ren HY, Zhang YC, Gao ZY, Lu DP. An improved anti-leukemic effect achieved with donor progenitor cell infusion for relapse patients after allogeneic bone marrow transplantation. Chin Med J (Engl) 2003;116:736-741
20. Huang XJ, Liu DH, Liu KY, et al. Modified donor lymphocyte infusion after HLA-mismatched/haploidentical T-cell-replete hematopoietic stem cell transplantation for prophylaxis of relapse of leukemia in patients with advanced leukemia. J Clin Immunol 2008;28:276-283
21. Thomas ED, Storb R, Clift RA, et al. Bone marrow transplantation (second of two parts). N Engl J Med 1975;292:895-902.
22. Shulman HM, Sullivan KM, Weiden PL, et al. Chronic graft-versus-host syndrome in man: a long-term clinicopathologic study of 20 Seattle patients. Am J Med 1980;69:204-217
23. Ottinger HD, Ferencik S, Beelen DW, et al. Hematopoietic stem cell transplantation: contrasting the outcome of transplantations from HLA-identical siblings, partially HLA-mismatched related donors, and HLA-matched unrelated donors. Blood 2003;102:1131-1137 (Pubitemid 36917816)
24. Takahashi S, Iseki T, Ooi J, et al. Single-institute comparative analysis of unrelated bone marrow transplantation and cord blood transplantation for adult patients with hematologic malignancies. Blood 2004; 104:3813-3820 (Pubitemid 39564462)
25. Chen SH, Li X, Huang XJ. Effect of recombinant granulocyte colony-stimulating factor on T-lymphocyte function and the mechanism of this effect. Int J Hematol 2004;79:178-184 (Pubitemid 38281820)
26. Zeng D, Dejbakhsh-Jones S, Strorber S. Granulocyte colony stimulating factor reduces the capacity of blood mononuclear cells to induce graft-versus-host disease: impact on blood progenitor cell transplantation. Blood 1997;90:453-463 (Pubitemid 27276592)
27. Olavarria E, Craddock C, Dazzi F, et al. Imatinib mesylate (STI571) in the treatment of relapse of chronic myeloid leukemia after allogeneic stem cell transplantation. Blood 2002;99:3861-2.3 (Pubitemid 34534565)
28. Oehler VG, Gooley T, Synder DS, et al. The effects of imatinib mesylate treatment before allogeneic transplant for chronic myeloid leukemia. Blood 2007;109:1782-1789 (Pubitemid 46239615)
29. Huang XJ. Current status of haploidentical stem cell transplantation for leukemia. J Hematol Oncol 2008;1:27.